Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FUNDC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TUBA3D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPIAL4C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ATXN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOTCH1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPM1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCHCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CEP70 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRGAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PROSER3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AAK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM161A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DZANK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on